These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
211 related articles for article (PubMed ID: 14759580)
1. Commercial preparations and handling of botulinum toxin type A and type B. Parish JL Clin Dermatol; 2003; 21(6):481-4. PubMed ID: 14759580 [TBL] [Abstract][Full Text] [Related]
2. Commentary: botulinum toxin in clinical medicine. Benedetto AV Clin Dermatol; 2003; 21(6):465-8. PubMed ID: 14759576 [TBL] [Abstract][Full Text] [Related]
3. Botulinum toxin for rejuvenation of the neck. Brandt FS; Boker A Clin Dermatol; 2003; 21(6):513-20. PubMed ID: 14759585 [TBL] [Abstract][Full Text] [Related]
4. Botulinum toxin-B and the management of hyperhidrosis. Baumann LS; Halem ML Clin Dermatol; 2004; 22(1):60-5. PubMed ID: 15158547 [TBL] [Abstract][Full Text] [Related]
5. Where has all the botox gone? (how) will we ever learn... using monoclonal antibodies to track botulinum toxin. Lim EC; Oh VM; Ong BK; Chow AW; Seet RC Med Hypotheses; 2006; 67(3):440-6. PubMed ID: 16678355 [TBL] [Abstract][Full Text] [Related]
7. Botulinum toxin in the lower one third of the face. Atamoros FP Clin Dermatol; 2003; 21(6):505-12. PubMed ID: 14759584 [TBL] [Abstract][Full Text] [Related]
8. History of the clinical use of botulinum toxin A and B. Carruthers A Clin Dermatol; 2003; 21(6):469-72. PubMed ID: 14759577 [TBL] [Abstract][Full Text] [Related]
9. Cosmetic uses of botulinum toxins for lower aspects of the face and neck. Lowe NJ; Yamauchi P Clin Dermatol; 2004; 22(1):18-22. PubMed ID: 15158540 [TBL] [Abstract][Full Text] [Related]
10. Botulinum toxin for the treatment of headaches: a review of current practices and evidence based-data. Ateş Y Agri; 2006 Jul; 18(3):5-11. PubMed ID: 17089224 [TBL] [Abstract][Full Text] [Related]
12. Comparison between intramuscular and perimuscular injections of botulinum toxin type A. Campos JH; Oliveira LB; Queiroz TO; Santos KP; Freitas FM Aesthetic Plast Surg; 2006; 30(6):700-3; discussion 704. PubMed ID: 16977369 [TBL] [Abstract][Full Text] [Related]
13. Treatment of unilateral masseter hypertrophy with botulinum toxin in two cases. Işeri M; Işeri PK Kulak Burun Bogaz Ihtis Derg; 2004; 12(3-4):99-102. PubMed ID: 16010109 [TBL] [Abstract][Full Text] [Related]
14. Type A botulinum toxin in the upper aspect of the face. Hexsel D; Dal'forno T Clin Dermatol; 2003; 21(6):488-97. PubMed ID: 14759582 [TBL] [Abstract][Full Text] [Related]
15. Botulinum toxin: a review of applications for the head and neck. Seidman LM; Brooks JK; Bashirelahi N Gen Dent; 2019; 67(2):55-58. PubMed ID: 30875307 [TBL] [Abstract][Full Text] [Related]
17. How to avoid complications when treating hyperdynamic folds and wrinkles. Sommer B Clin Dermatol; 2003; 21(6):521-3. PubMed ID: 14759586 [TBL] [Abstract][Full Text] [Related]
18. [A new possibility for focal treatment of spasticity with botulinum neurotoxin. The Danish Society of Neurology]. Jeppesen LL; Dalager T; Meden P Ugeskr Laeger; 2004 Mar; 166(12):1117. PubMed ID: 15067776 [No Abstract] [Full Text] [Related]
19. Botulinum toxin type B for dynamic glabellar rhytides refractory to botulinum toxin type A. Alster TS; Lupton JR Dermatol Surg; 2003 May; 29(5):516-8. PubMed ID: 12752520 [TBL] [Abstract][Full Text] [Related]
20. [Botulinum toxin. Development for therapeutic purposes]. Ceballos-Baumann A Nervenarzt; 2008 Jun; 79 Suppl 1():3-8. PubMed ID: 18927957 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]